CD14 and graft versus host disease: The immunosuppressive function of CD14+HuMoSC supernatant was assessed in combination with immunosuppressive drugs usually prescribed for GvHD prevention such as methotrexate (MTX), cyclosporine A (CsA) and methylprednisolone (MP).